Clinicians should be aware of the increased risk of developing UTUC in a patient who has LS. Conversely, clinicians should consider LS in patients who present with de novo UTUC. Clinical and molecular tools exist to aid in the diagnosis; the role of germline testing is evolving.
Chelluri et al. (Wed,) studied this question.